Albireo Pharma Inc
(ALBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | EVMN | PCRX | ||
| Company | Albireo Pharma Inc | Evommune Inc | Pacira Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 44.90 | 28.38 | 21.28 | ||
| High | 44.90 | 29.64 | 22.02 | ||
| Low | 43.99 | 24.12 | 20.88 | ||
| Latest | 44.15 | 28.46 | 21.73 | ||
| Change | -0.10 | -0.57 | +0.49 | ||
| % Change | -0.23% | -1.96% | +2.31% | ||
| Volume | 1,241,200 | 1,261,400 | 710,800 | ||
| 20-Day Average Volume | 635,260 | 1,107,950 | 933,675 | ||
| Previous Close | 44.25 | 29.03 | 21.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 19.86 | 20.64 | ||
| 20-Day Raw Stochastic | 43.90% | 72.49% | 78.03% | ||
| 20-Day Relative Strength | 72.09 | 65.64 | 47.82 | ||
| Weighted Alpha | +16.30 | N/A | -17.04 | ||
| Today's Opinion | 88% Buy | N/A | 88% Sell | ||
| Previous Opinion | 100% Buy | N/A | 88% Sell | ||
| Last Month's Opinion | 100% Buy | N/A | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | +50.26% since 02/04/26 | +5.08% since 02/04/26 | ||
| Low | 43.53 on 02/24/23 | 15.97 on 02/09/26 | 20.24 on 02/05/26 | ||
| High | 44.90 on 03/02/23 | 33.20 on 02/10/26 | 22.02 on 02/11/26 | ||
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | +41.38% since 01/09/26 | -7.65% since 01/09/26 | ||
| Low | 43.31 on 02/23/23 | 15.97 on 02/09/26 | 18.80 on 01/20/26 | ||
| High | 45.23 on 02/03/23 | 33.20 on 02/10/26 | 23.85 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +46.17% since 11/11/25 | -9.91% since 11/11/25 | ||
| Low | 17.78 on 12/27/22 | 13.89 on 12/18/25 | 18.80 on 01/20/26 | ||
| High | 45.23 on 02/03/23 | 33.20 on 02/10/26 | 27.16 on 12/16/25 | ||
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | N/A since 11/06/25 | -13.74% since 08/11/25 | ||
| Low | 16.02 on 09/07/22 | 13.89 on 12/18/25 | 18.80 on 01/20/26 | ||
| High | 45.23 on 02/03/23 | 33.20 on 02/10/26 | 27.64 on 09/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 915,142 | 913,766 | ||
| Shares Outstanding, K | 20,701 | 31,524 | 43,021 | ||
| Annual Sales | 40,580,000 | 7,000,000 | 700,970,000 | ||
| Annual Net Income | -34,030,000 | -66,810,000 | -99,560,000 | ||
| Last Quarter Sales | 9,830,000 | 10,000,000 | 179,520,000 | ||
| Last Quarter Net Income | -37,800,000 | -12,480,000 | 5,430,000 | ||
| 60-Month Beta | 1.03 | N/A | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | -8.07 on 12/11/25 | 0.70 on 11/06/25 | ||
| Latest Earnings Date | 03/07/23 | 10/16/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 10.38 | ||